Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
Simplifying the URD Selection Process for HCT
Biol Blood Marrow Transplant.; ePub 2018 Feb 14; Shaw, Logan, et al
Simplifying the unrelated donor (URD) selection process for hematopoietic cell transplantation (HCT) appears to be feasible, researchers concluded after conducting a study involving >10,000 individuals. Investigators sought to develop and validate a donor selection score that emphasized donor characteristics linked with better survival in participants who received HCT from 8/8 HLA-matched URDs between either 1999 and 2011 (n=5,952) or 2012 and 2014 (n=4,510). Patients were broken into training and test sets at a 2:1 ratio. Among the results:
- Donor selection score could not be validated.
- Younger age was the only donor characteristic linked with better survival; 2-year survival was 3% better when donors were 10 years younger.
The authors noted that their findings indicate that clinicians can be flexible in selecting URDs based on characteristics other than age.
Shaw B, Logan B, Spellman S. Development of an unrelated donor selection score predictive of survival after HCT: Donor age matters most. [Published online ahead of print February 14, 2018]. Biol Blood Marrow Transplant. doi:10.1016/j.bbmt.2018.02.006.